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Abstract. Laser acceleration promises innovation in particle beam therapy of cancer where an 
ultra-compact accelerator system for cancer beam therapy can become affordable to a broad 
range of patients. This is not feasible without the introduction of a technology that is radically 
different from the conventional accelerator-based approach. Because of its compactness and 
other novel characteristics, the laser acceleration method provides many enhanced capabilities 
for the radiation oncologist. First, it reduces the overall system size and weight by more than one 
order of magnitude. This is due not only to the compactness of the accelerator component, but 
also to reduced radiation shielding requirements, fewer proton magnets, and the compactness of 
the gantry. In addition to this ultra-compact size, the characteristics of the particle beams 
(protons) make them suitable for a class of therapy that might not be possible with the 
conventional accelerator, such as the ease for changing pulse intensity, the focus spread, the 
pinpointedness, and the dose delivery in general. Some new methods of therapy may be derived 
from these characteristics. A compact, uncluttered system allows a PET device to be located in 
the vicinity of the patient in concert with the compact gantry. The radiation oncologist may be 
able to irradiate a localized tumor by scanning with a pencil-like particle beam while 
ascertaining the actual dosage in the patient with an improved in-beam PET verification of auto-
radioactivation induced by the beam therapy. This should yield an unprecedented flexibility in 
the feedback radiotherapy by the radiation oncologist. Assisted by this, irradiation scanning 
based on the minute beam structure of laser accelerated particle beams well conforms to the 
small size of early stage tumors. In order to improve advance experimental achievement, we 
introduce a series of innovations intended to enhance the energy and quality of accelerated ions 
with the laser acceleration method.  This technology will drive the development of a new class 
of beam therapy, which is highly localized, specific and has been termed biologically conformal 
radiation therapy (BCRT). In a clinical point of view, this compact and sophisticated laser 
accelerated proton radiotherapy at lower energies near 60-80MeV can be applicable to the 
disease lying a few centimeter under the skin, such as eye tumors, age-related macular 
degeneration (ARMD), laryngeal cancer, nasal or paranasal tumor, breast cancer, and so on. 
Laser accelerated radiotherapy has a unique niche in a current world of high energy accelerator 
using synchrotron or cyclotron. 
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INTRODUCTION 
 
Although the technique for targeting X- or γ-rays for tumor treatment volumes has 
greatly improved in recent years, the radiation exposure to normal tissues around the 
tumor is still significant and limits the maximum dose available for sterilizing tumor 
cells. Particle beams, including protons and carbon-ion beams, provide a way to 
resolve this problem, because damage to normal tissue around the tumor is minimized 
due the effects of the particles’ Bragg peak.1 
According to a worldwide survey report,2 as of July 2004 there were over 48,000 
patients (42,700 by proton, 1,100 by pions and 4,500 by ions) treated by particle ion 
beams at 25 institutes. Usually, particle beams are accelerated by a synchrotron or 
cyclotron facility. These conventional  accelerators are based on radio-frequency (RF) 
technology. In addition, many bending magnets are required for ion beam transport to 
the procedure rooms and for providing conformal irradiation of the tumor target (the 
gantry systems). These must be accompanied by the adequate radiation shielding. 
Laser acceleration of charged particles,3 however, may provide a viable alternative 
technology for hadron therapy.4 5 6 7 8 9 10 
Since the first high power laser proton acceleration experiments11 12 13 in 2000 there 
has been world-wide experimental research14 15 16 to ascertain and improve the laser 
acceleration of ions, as well as more theoretical and computer simulations (see review 
articles17 18 19 and literature quoted in). Various aspects of radiotherapy using laser 
accelerated ions have been previously addressed in the above cited papers. In this 
paper we aim to expand on some of these ideas. We address real time verification 
methods which are enabled by laser accelerated protons.  We use previously presented 
multi-parametric studies to find an optimal scheme for acceleration of ions with 
double layer targets for increasing the maximum energy and efficiency for a given 
laser pulse energy. Although the basic mechanisms are quite well known from theory, 
simulations, and experiments, medical applications require new mechanisms of 
acceleration. In this paper we propose a new acceleration mechanism, adiabatic 
acceleration. The present paper is organized as follows: (1) as an important 
background for this paper, we will review the already known and newly recognized  
distinctive features and limitations of present laser driven proton accelerators, (2) 
examine methods for optimization including energy maximization and adiabatic 
acceleration, and (3) propose specifications of the laser accelerator for producing the 
required quality hadron beams, and examine the clinical availability and innovative 
potential for making these unique treatments feasible by this enabling technology. As 
a result we shall show a future vista of novel radiotherapy based on the laser 
accelerator approach. 
 
CHRACTERISTICS OF LASER DRIVEN PARTICLE 
THERAPY 
 
 General 
 
A laser ion accelerator is expected to be compact, simple, and low cost. Some of the 
reasons for this are shown in Table 1. This is based on several factors: We can 
compactify the system so that it can be accommodated in existing hospital 
infrastructures. The gantry is small, containing no large magnets (unlike charged 
particle beams, no magnets are necessary for laser photon transport) and radiation 
shielding is only local (instead of shielding an entire accelerator section, as in the 
conventional case). The accelerator itself is tiny (relative to conventional ones) where 
the most expensive element in our machine is the laser. Because lasers are rapidly 
getting cheaper and more powerful, it is anticipated that they will significantly 
contribute to the widespread use of proton therapy throughout the world.  The 
irradiation system of a laser ion accelerator is a multi-terawatt system with a final laser 
pulse compressor, an ion beam generation chamber, a separation magnet system and a 
patient positioning system. These features are remarkable in comparison with 
synchrotron or cyclotron accelerators.20 These days compact, few hundred TW lasers 
that can easily fit into typical hospital radiotherapy treatment rooms are commercially 
available. These innovative features amount to a proton therapy device that is 
comparable in size to currently employed linac X-ray machines in many typical 
hospitals. This allows one to reduce the cost of the infrastructure of a proton therapy 
facility.  A typical experimental setup of laser acceleration of ions looks like that in 
Fig.1, being of miniature size. 21 In the future the real device will be an order of 
magnitude smaller than those laser systems and interaction chambers presently 
intended for fundamental science studies. 
TABLE 1.Characteristics of a laser driven particle therapy machine 
 
Parameter 
 
Conventional accelerator 
 
Laser driven accelerator 
 
Beam 
transport 
 
Large magnetic system required to 
bend charge particles 
Radiation shielding required 
around the bending corner 
 
Laser beam can be transported and 
bended by mirrors (small device). 
Radiation shielding not required 
around the bending corner 
 
Accelerator 
 
Large magnetic system required to 
accelerate charge particles 
Total system is large and overall 
radiation shielding required 
 
Only target part should be irradiated. 
Compactification of the system 
possible 
 
Irradiation 
system 
 
The three to five meter magnet 
system required to bend charged 
particles 90-135 degrees with 
gantry 
 
Small size magnet to bend 10-30
degrees (one tenth of conventional 
one in size) 
 
Gantry 
 
Large size (100-250 tons) 
Diagnostic system cannot be set 
near patient 
 
Small size (1-10 tons) 
Diagnostic system can be combined 
with gantry. 
 
Scanning 
 
Mainly long pulse injection 
Recently started 
 
Short pulses superimposed 
Main method 
 
Technology 
 
Matured (started since 1930s) 
 
Nascent (started since 1990s) 
Many elements to be developed 
 
Others 
 
 
 
Protective goggle required 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.Experimental setup of repetitive laser-driven accelerator, which can be hand palm size. The 
actual medical device needs some energy separator and radiation shield etc., which amounts to a 
physical extent of order 1m according to Ref.22 (see Fig.2). The laser pulse length, intensity, direction, 
spot position etc. are easily controlled so that the resultant proton beams may be produced to the desired 
specification. 
 
Compactness of the System 
 
 Beam transport 
 
The beam transport system of a laser ion accelerator is much different from that of 
conventional ion accelerators. Unlike the latter, ion acceleration would take place in 
the gantry (or certainly in the patient’s room) rather than at a distant site. There would 
be no ion injector. There would be no large bulky transport magnets. Whereas charged 
particles such as protons and carbon ions are bent by magnets, laser light is redirected 
in transport by mirrors. The final mirror (or mirrors) would focus the laser onto a 
target that is itself an accelerator of the size comparable to the palm of a hand or at 
most an arm.  
 
 Irradiation system and gantry 
 
Another key advantage of laser accelerators is that they can be naturally incorporated 
into the transport system, i.e. they do not involve a large number of magnets.5 The 
generated proton beam would be transported, bent, and focused onto the patient 
through a system of magnets and shields that separate unwanted components of 
radiation, including protons of undesired energies. Such an example has already been 
suggested.5, 22One of the reasons for the need for the large number of magnets in the 
gantry is that in conventional accelerators protons of 200 MeV need to be bent by 
magnets typically by 135 degrees. By contrast laser accelerated protons are generated 
much closer to the patient so the typical bending angle would be a mere 10 or 10’s of 
degress.22  
 Acceleration gradient 
 
In the case of a laser accelerator, the acceleration gradient is several orders of 
magnitude greater (of order ~100 GeV/m) than that of typical conventional RF 
technology (which is of order 10 to 100 MeV/m). This raises expectations for 
providing much more compact therapy devices. The limit for conventional 
accelerators is due to rf cavity breakdown.23  
 
 Characteristics of laser-driven particle beams 
 
Laser energy delivery and therapy of small early tumors 
 
As diagnostic methods improve over the next decade (e.g., molecular imaging, 
magnetic resonance imaging, magnetic resonance spectroscopy and other advanced 
sensitive detection techniques or functional imaging), earlier detection of smaller 
tumors may become a reality. This not only helps to avoid metastasis, but also 
facilitates flexibility and ease of cure. We envision therapy of millimeter size tumors 
rather than centimeter size in the future. The conventional accelerator typically 
delivers 1010 particles per pulse. Many laser experiments that have been carried out so 
far can yield about 109 particles per pulse (however, parameters widely vary and it is 
not so meaningful to mention just one parameter). 
It is important to note that (1) in terms of energetics there is an ample margin for a 
laser accelerator to meet the desired fluence (or number) of protons, while (2) with 
regard to realizing this new technology that is radically different from conventional rf 
accelerators (synchrotron or cyclotron), one needs a series of innovations that match 
the requirements of medical applications. In many analytical9 and simulation24 studies, 
intensities of 1020-21 W/cm2 are necessary to generate ions over 100 MeV. This 
suggests that we need laser irradiation of peak power 100 TW or more (if focused onto 
an area of 10-3 cm x 10-3 cm or smaller). A 100 TW laser pulse of duration 100 fsec 
contains 10 J of energy. Suppose that this laser operates at a 10Hz  repetition rate and 
we irradiate for 100 seconds (of course, the rate can be changed to conform with the 
treatment program, but here we assume only one fraction) to deliver a 70Gy dose to an 
early stage tumor of mass, 1gram. The total needed proton energy deposited in the 
tumor is 0.07J which amounts to 0.07mJ per laser pulse. Because the single laser pulse 
energy under consideration is 10J, we only need to transfer a small fraction (10-5) of 
the laser pulse energy into proton energies of therapeutic relevance. Some of the 
current experiments typically deliver 1% of laser pulse energy to protons, though 
again this efficiency varies from experiment to experiment.  On the other hand, as we 
shall discuss later, if more efficient adiabatic acceleration is realized, the energy 
fraction converted from the laser to proton beam (energy conversion efficiency) is 
significantly greater, which means that we can consider much lower power laser 
systems which can be easier to develop and more compact. 
 
 
 
Flexible combination of therapy beams and diagnostics 
 
It is known that in-beam positron emission tomography (PET) is the only method 
for non-invasive in situ monitoring for hadron therapy.25 The smaller gantry affords 
flexibility in installing in-beam PET. In addition development in precise irradiation 
and diagnostic imaging will make it possible to develop patient specific irradiation 
therapy which is termed biologically conformal radiation therapy (BCRT).26 This will 
result in scanning therapy with increased accuracy with reduced dosage.  
 
Precise Irradiation 
 
To achieve precise irradiation of irregularly shaped tumor targets via beam scanning 
irradiation, studies have shown the following requirements for medical accelerators:27 
28 a) beam size control, b) intensity control, c) fast beam cut-off, and d) time-structure 
control. Although these requirements can be achieved using conventional 
accelerators,28 it can be much easier to achieve them using laser accelerated particle 
beams.  
Concerning a), the laser ion accelerator has the advantage of generating narrow 
proton beams. From several experimental or simulation data, narrow proton beams of 
50-200 micron diameters 29 can be available. Consequently, a variety of beam sizes 
built up from narrow beams and small spots via beam scanning.  
Concerning b), the proton beam intensity can be easily controlled by laser energy 
for a fixed laser pulse duration and spot size. The output proton beam energy and flux 
would change according to the modulation of the laser intensity. Changing the energy 
of the proton beams can be done more quickly than in current accelerators because the 
laser intensity can be changed easily and quickly by changing the laser energy. These 
features make it possible to treat minute shallow targets precisely using the spot 
scanning technique.30 These features will become more attractive and relevant as the 
early detection and diagnosis of cancer are expected to improve over the next 
generation.  
When dynamic beam modulation of spot scanning is used, further dose 
concentration to the tumor  than in the static case is anticipated. A tumor is divided 
into individual voxels, and the laser pulse intensity of each voxel is modulated 
corresponding to the required proton beam energy. The variation of laser intensity 
from one voxel to another is rapid and the change of the proton energy is 
correspondingly rapid. So, laser intensity modulated proton therapy (IMPT) driven by 
laser is a promising method for spot scanning.31 We are aiming at highly accurate 
particle radiotherapy.  
Concerning c) and d), another unique feature of laser accelerated protons is the 
short pulse duration (typically picoseocnds instead of the hundreds of nanoseconds 
typical of a conventional accelerator). Because such short proton pulses can clearly be 
controlled by turning the laser pulses on or off, extremely fast pulse cut-off and time-
structure control are possible in contrast to conventional accelerators. This is directly 
attributed to the picosecond temporal structure of the laser produced proton beams.  
 
 
Precise real time verification and image guided proton radiotherapy 
 
An additional requirement for precise irradiation is on-line or real time diagnostic 
imaging. The integration of diagnostics with the therapy allowing image guided 
therapy in intensity-modulated radiotherapy (called as tomotherapy) has already been 
recognized as highly desirable.32 We previously reported that a PET camera can detect 
positron emitters, consisting mainly of 11C, 13N and 15O along the proton beam 
trajectory.33 At HIBMC the PET examination room is situated near the treatment 
room. The PET image is clinically very useful for the examination of patients, because 
we can easily verify the extent, angle, and the volume irradiated by proton beams. A 
laser driven proton accelerator will be sufficiently compact to include an in-beam PET 
camera into the irradiation system (Fig. 2) that allows us to improve the usage of the 
in-beam diagnostic PET operation with the scanning radiotherapy treatment.34 35 25 
With current in-beam PET scanning, the counting statistics are low due to low 
detection efficiency over limited angles and random coincidence effects due to 
secondary gamma photon emission.36 37These gamma photons contaminate PET 
signals during beam irradiation, rendering the noise level of gamma radiation high 
compared with the positron annihilation gamma signal due to auto-radioactivation by 
proton irradiation. Suppression of this noise is achieved by placing time windows on 
the data (gating).37 Compared to conventional accelerator systems, laser accelerated 
short particle beams enable for much more accurate specification and positioning of 
the time windows as well as a reduction of the integrated time over which this noise 
due to secondary gamma emission occurs. In addition due to the compact size of laser 
accelerators there are fewer constraints on the placement of a closed-ring PET 
detector, which has better resolution than a dual-head PET detector.38 Consequently, 
improved real time verification of auto-activation will be available with higher 
counting statistics due to the larger possible detection solid angles and higher noise 
suppression. This is expected to clarify the relationship between the intensity of 
proton-induced activities and tissue components. Ultimately, we aim to control the 
prescribed radiation dosage in real time measuring positron emitters generated 
immediately after irradiation. Real time verification of proton dose allows precise and 
safe treatment of small tumors such as eye melanoma. For larger invasive tumors such 
as H&N tumors, we can apply the technique to improvement in local control by 
increasing the intensity to radio-resistant part in the tumor. 
 
Enhanced therapy accuracy using shorter lived positron emitters 
 
It is recognized that by having an in-beam PET detector that shorter lived positron 
emitters can be used for imaging.39 Figure 3a illustrates proton irradiation of water, 
simulated by the Monte Carlo Particle and Heavy Ion Transport code System, PHITS 
40 in the case where a proton pencil beam of energy 200 MeV with a 10 mm diameter. 
PHITS is used in various fields, such as radiation shielding of accelerator facilities, 
radiotherapy, and space technology. Nuclear reactions are clearly seen along the 
proton tracks. Figure 3b (3c) shows the two- dimensional distribution of the residual 
nuclei, 15O (11C) in water determined by PHITS. These residual nuclei have a short 
half-life of 2 (20) minutes. Positrons are created during β+-decay they are  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2.Conceptual laser accelerated proton therapy instrument. Compact and flexible radiotherapy 
and dose verification synergy due to the innovation of the laser proton acceleration combined with an 
in-situ real-time PET camera. The compactness of the laser acceleration introduces significant 
flexibility in operating real-time PET verification, which allows the radiation oncologist to render far 
more affordable and accurate cancer therapy to the patient. 
 
subsequently annihilated in encounters with electrons. A pair of gamma photons 
results from the electron-positron annililation process.  Comparison of the figures 3b 
and 3c shows that the number of 15O residual nuclei is far greater than the 11C residual 
nuclei.  This is mainly due to the larger production cross section.i This illustrates that, 
with in-beam PET, using 15O as the more abundant positron emitter with the shorter 
half life can enhance PET imaging. 
 
Limitations 
 
To date, the maximum experimentally measured laser-accelerated proton energy has 
been limited to several tens of MeV.17 18 19 42These proton energies can penetrate to 
depths of several centimeters in the human body. With proton energies limited to 50 
MeV, only 4 of 778 patients (0.5%) were treated between May 2003 and Oct 2005 at 
HIBMC. Three of the four were H&N cancer where two were nasal cavity malignant 
melanoma and one was an orbital tumor. The remaining one of the four was lung 
cancer near the chest wall. The proton ranges were 34mm, 45mm, 48mm, and 38mm, 
respectively.   
Laser-accelerated proton beams are typically emitted with measurable diverging 
angles. However, the beam still originates from a tiny laser focus so that the transverse 
emittance is quite small  (typically one order  magnitude smaller  than  of conventional 
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FIGURE 3.Monte Carlo simulation of radio-activation of nuclei by proton beams. (a) The flux of 
protons for the case of a proton pencil beam of energy 200 MeV with a 10 mm  diameter irradiating 
water from the left where the water boundary starts at 5cm. (b) The two-dimensional distribution of 
residual nuclei: 15O in water. (c) The two-dimensional distribution of residual nuclei: 11C in water. 
 
accelerators). Thus it can be easy to refocus laser-accelerated protons with magnets or 
other means. The energy spectra with a single-layer metal target are broad and typical 
of a thermal distribution. We had suggested a method5 for producing quasi-
monoenergetic proton beams using tailored targets. This mechanism has been 
confirmed with computer simulations7,43 and has also been experimentally 
demonstrated.44  In addition, selective collimation, energy selection (filtering), and 
focusing even for proton beams with broad energy spectra and broad divergence have 
been shown to be possible experimentally via an ultra-fast laser-driven microlens.45 
It is also necessary to develop techniques to remove particles other than protons 
(heavy ions, electrons, gamma-rays, neutrons, etc), which are also emitted from the 
target as a result of the laser-target interaction.22  For laser-accelerated protons, the 
desired beam direction can be set by choosing the laser irradiation direction and 
magnets are introduced only for the segregation of the desired beam components from 
other non-desired ones. Therefore, magnetic field levels (and thus the size of magnets) 
can be almost an order of magnitude lower than those used in a conventional gantry, 
where a charged beam is typically bent by 90 degrees or 135 degrees. 
 
 
 
 
 
OPTIMIZED LASER ACCELERATION 
 
Methods of investigation 
 
Specific features of laser-accelerated proton therapy require development of 
simulation tools46 which include (1) particle-in-cell simulation (PIC) software47 which 
calculates the properties of laser-accelerated protons, (2) Monte-Carlo simulation 
codes PHITS40 and GEANT448 for dose calculations in the human body, and (3) 
visualization tools for the dose evaluation. We have carried out simulations of laser-
accelerated proton therapy using these. 
For the Monte-Carlo simulations, CT values, in Hounsfield units, were used to 
determine a material for each voxel following the work of Schneider.49 Adjacent CT 
values were averaged to yield a pixel size of 1.25 by 1.25 mm. The slice thickness was 
2.5 mm. A spot scanning method was employed. The spacing between target spots can 
be specified, or computed automatically based on a pre-computed database of dose 
profile curves in water. For these tests, we specified a lateral and depth spacing of 2 
mm.   
Based on earlier PIC simulation results, we chose a Gaussian energy spread of 10% 
and a beam diameter of 5 mm. A mono-energetic particle beam can be aimed directly 
at a critical structure, relying on the sharp Bragg peak fall off, but a particle beam with 
high Gaussian energy spread results in a relatively long distal dose drop-off curve. For 
this reason, we chose to direct the beam from the side, sometimes even through the 
bones around the eye socket.  
The multi-parametric simulation is a technique, in which a series of many tasks with 
different sets of the laser and target parameters is performed simultaneously on many 
processors of a multi-processor supercomputer (Fig. 4). Each set of parameters 
constitutes an individual task, which is performed using the massively-parallel and 
fully vectorized code REMP, based on the PIC method and the “density 
decomposition” scheme.47 In a two-dimensional model of the laser-plasma interaction, 
it is possible, in principle, to perform an individual task on a small machine, e. g. 
personal computer. However, in order to test a large number of different initial 
conditions with one processor unit it is necessary to run tasks sequentially which can 
take years to complete. The necessary processing time can be greatly reduced if all the 
tasks are processed in parallel on a massively-parallel supercomputer or GRID system.  
 
Target thickness optimization 
 
Characteristics of laser-driven ion beam can be controlled by changing the parameters 
of the laser pulse and the target. For example, the accelerated ion beam emittance can  
be set by shaping the foil target – because ions are accelerated in the direction 
perpendicular to the target surface, bending the foil target can focus the emitted proton 
beam.50 The energy spectrum of the ion beam can be set by shaping the target and 
changing its composition. To obtain quasi-mono-energetic ion beams, the scheme of a 
double layer target was developed.5 7 43 51 In this scheme, a sufficiently intense laser 
pulse sweeps a significant portion of electrons from a thin target building the   
 
 
FIGURE 4.  The scheme of multi-parametric Particle-In-Cell(PIC) simulation. Each individual set of 
parameters, represented by a tile, is processed in one run by one processor unit. Results from multiple 
runs inlay a mosaic in the parameter space, from which scaling laws can be seen. 
 
accelerating electrostatic potential. Figures 5a and 5b show the results of three-
dimensional PIC simulation for two cases, when the transverse size of the double-layer 
target is comparable to the laser focal spot and when it is much greater than the laser 
focal spot. In both cases targets are irradiated by 30J 65 fs laser pulse with peak 
intensity 1021W/cm2. In the first case, the protons are initially localized in a dot 
coating, with transverse size much less than the laser focal spot, thus ions see an 
almost homogeneous accelerating field and the resulting energy spectrum is quasi-
mono-energetic (Fig. 5a). In the second case, the protons form a wide coating on the 
rear side of the target. In this case protons, which were initially sufficiently far from 
the laser pulse axis, acquire less energy than ions near the laser pulse axis, because the 
transverse scale of the accelerating electric field is comparable to laser focal spot. 
Although the accumulated spectrum is approximately thermal, the central portion of 
the ion beam is quasi-mono-energetic since the ion motion is almost laminar. This 
beamlet can be extracted, e. g., by a screen (Fig. 5b). 
Knowing the dependence of the ion energy on target and laser characteristics is of 
crucial importance for practical implementations and optimization. Here we present an 
example of how such the dependence can be foreseen.  
We investigate the ion acceleration from a double layer target 5 7 43 52 driven by a 
laser pulse with multi-parametric Particle-in-Cell (PIC) simulations. 24 
 
              
 
FIGURE 5. Toward more mono-energetic beams. (a) Laser-driven ion acceleration at a spot-size 
double-layer target. (b) Laser-driven ion acceleration at a wide double-layer target. 
 
We analyze the dependence of the interaction products  (such as the ion beam energy,  
emittance, the acceleration time, pulse duration, as well as laser light reflection, 
transmission and absorption coefficients, etc…) on the following laser pulse and the 
target parameters: laser pulse intensity I, focal spot size ℓlas⊥ and duration ℓlas/c, target 
density ne and thickness lpl. Simulations were performed on 720-processor HP Alpha 
Server at JAEA-Kansai. In each processor the grid consists of 4016×2176 cells and the 
number of quasi-particles is 1.9×107. The simulation box size is 251λ×136λ, where λ 
is the laser wavelength (typically 1 micrometer). The laser pulse initially propagates 
along the x-axis. The target consists of two layers, the first layer is fully stripped 
aluminum and the second layer is a proton coating. The transverse size of the first 
layer is 80λ, for the second layer it varies with the laser pulse focal spot size as ℓlas⊥/2. 
The second layer is 0.06λ thick, its density is such that the number of ions in the first 
layer in the longitudinal direction is 103 times greater than the corresponding number 
of protons. At chosen conditions, the proton layer is accelerated as a whole. The 
resulting accelerated ion beam is a pulse of 107-109 protons with transverse emittance 
less than 0.3 mm⋅mrad, (meeting  the corresponding requirements of the proton 
therapy).  
We study the idealized model, with a simple target and laser geometry, in order to 
simplify interpretation and to avoid screening of important material by numerous 
unimportant details. In experiments, laser pulses have low-intensity intervals, such as 
pre-pulse (from amplified spontaneous emission (ASE) and other sources), which can 
alter the structure of the solid target before the main short  laser pulse arrives. That is, 
a preplasma is typically formed, as discussed in, 14 16 42 53. Despite the idealization, 
results of our multi-parametric analysis are useful even for interpretation of the laser-
foil interaction complicated by the prepulse, which changes the target density and 
scale length. Upon arrival, the main, high-intensity, part of the laser pulse meets a 
modified target, which can be approximated as a plasma slab of some density and 
thickness. From this moment the interaction can be described by our model, because 
the energy of relativistic processes in the electromagnetic wave interaction with 
plasmas is significantly higher than that of  non-relativistic  hydrodynamics associated 
(a) (b) 
 
FIGURE 6.Optimization of the target thickness for given laser intensity. Dependence of ion beam 
energy on the target thickness and density, when the target is irradiated by the laser pulse of intensity 
5×1021W/cm2, duration 10λ , and focal spot 10λ, and a correlation between ion beam energy and laser 
pulse reflection, absorption and transmission coefficients. 
 
with melting (evaporating) the thin target. In other words, instead of predicting a 
particular preplasma condition, our goal is to consider all possible plasma conditions.  
While scanning different target thicknesses lpl=0.1…5λ , densities ne=1…100 ncr 
(where ncr=πmec2/λ2e2 is the critical density), and laser intensities I=1020…1022 W/cm2 
for fixed laser pulse length and focal spot size ℓlas= ℓlas⊥=10λ, we found that the 
highest ion energy gain occurs at certain electron areal density of the target σ=nelpl, i. 
e. the number of electrons integrated along the longitudinal direction per unit area 
(Fig. 6).  
Thus the energy dependence on two parameters ne and lpl degenerates to a 
dependence on only one parameter σ, even though we can identify at least three 
different mechanisms for the ion acceleration in different regions of parametric space. 
At small thickness lpl and large density ne the laser pulse sweeps away a substantial 
fraction of electrons and the induced strong Coulomb potential of the first layer 
accelerates protons, in accordance with the scenario described in Refs. [5 7 9 43 52]. 
At large thickness and small density the laser pulse penetrates through the target and 
generates a strong quasi-static magnetic field whose pressure causes charge separation 
which accelerates protons near the plasma-vacuum interface, similar to the mechanism 
suggested in Refs. [16 54 55]. Somewhere between these two extreme regions we can 
see the ion acceleration due to ambipolar expansion of the hot electron cloud into 
vacuum.56 57 58 59 The degeneracy in dependence of the ion energy on target density 
and thickness can be interpreted as follows. Ions are accelerated by the electrostatic 
field of the charge separation caused by the laser pulse. The electrons, if their number 
is large, can form the electric current which is sufficient to reflect the laser pulse. 
 
FIGURE 7.Dependence of ion beam energy from the laser pulse power. 
 
However this current cannot exceed the limiting electric current −enec. Therefore, with 
increasing laser intensity, the reflection becomes less efficient, the plasma becomes 
more transparent and at some point all the electrons are involved  in  the  interaction.    
With    even greater laser intensity, even more electrons can be disturbed, providing 
stronger charge separation. Consequently a smaller number of electrons will not be 
optimal. Thus for every value of the laser intensity there is a certain optimal limiting 
electric current formed by a certain number of electrons in the slab. Since this effect is 
mainly one-dimensional, the limiting current is defined by the electron areal density of 
the slab, as in Refs. [60 61]. 
The maximum of the ion energy gain corresponds to a particular optimal electron 
areal density σopt. For σ<σopt, more laser pulse energy is transmitted through the 
plasma slab. For σ>σopt, the laser pulse reflection becomes more efficient. At σ=σopt, 
the absorption of the laser energy is optimal for the ion acceleration. The proton 
energy spread is below 5% for σ<σopt, and it increases for σ>σopt, as the maximum 
energy decreases. The optimal electron areal density depends almost linearly on the 
square root of the laser intensity, σopt≈3+0.4 I1/2. This is similar to the criteria of 
relativistic transparency of a thin foil.60 61 Varying the σ, one can find the minimum 
intensity which gives the desired ion energy gain. In other words, at each intensity 
there is an optimal σ which provides the maximum energy gain. For highest 
achievable ion energy with each pair of parameters (lpl, ne), one is led to an optimized 
scaling  
Ip ∝ε                                                              (1) 
Changing the laser pulse duration and the target thickness, we can further control the 
output ion beam energy.  Figure 7 shows the dependence of the energy of the ion beam 
accelerated with a double-layer target of density 100ncr  rearranged as a dependence of 
ion energy on laser pulse power (derived from laser intensity, duration, spot size and 
target thickness). In the case of thin targets of given thickness and optimal laser pulse 
duration, the proton energy scales as the square root of the laser pulse power24.When 
the radiation pressure of the laser field becomes dominant, which corresponds to 
intensities of the order of 1022 W/cm2, the proton energy becomes proportional to the 
laser pulse energy and protons can be accelerated to relativistic energies.62 63 Figure 7 
represents the functional dependence with a fixed density. As we shall see in 
subsection D, if we eliminate the abruptness of the present acceleration, further 
increase of ion energy is obtainable. 
 
 
Energy scaling of ions with respect to the laser pulse length 
 
We discuss the energy of accelerated ions with respect to the laser pulse duration 
(within the ultra short pulse regime, which is subpicoseconds). The regime presented  
above for high quality proton beam acceleration requires an adequately high laser 
pulse intensity. In order to expel almost all the electrons from the focual region the 
laser electric field, Elas=(4I/c)1/2, must be larger than the electric field that is formed 
here due to the electric charge separation  
pleenE ?π20 ≈  .              (2) 
From the geometry of charge formation for sudden blowout sheath acceleration, the 
longitudinal length of ion acceleration is at most that of the electron acceleration 
length. This in turn is approximately that of the transverse laser focal spot size ℓlas⊥. 
Thus the fast accelerated proton energy is 
                                               ⊥= lasp eE ?0ε  .                                        (3) 
 
On the other hand, the acceleration length of the electrons is  
 
                                              λ0aacc =?                                            (4) 
where 0 0 / ea eE m cω=  is the dimensionless laser pulse amplitude, ω  and 2 /cλ π ω=  
are the laser frequency and wavelength respectively. For optimal usage of laser energy 
this length ℓacc should be also of the order of ℓlas.  In the non-relativistic ion regime of 
current study, the acceleration time is equal to  
 
                                 
2/1
0 )/2( eEmilasacc ⊥= ?τ  .                                    (5) 
until it reaches the plateau value ℓacc = ℓacc/c. This is the optimum from both the ion 
energy and invested laser power. At this optimal point, the required laser pulse length 
is 
                     
2/1)/)(/2( pllaspilas c ??? ⊥= ω  .                            (6) 
Here npi=(4e2ne/mi)1/2   is the ion plasma frequency. 
In order to optimize the proton energy, it is important to increase the laser efficiency 
and we increase the pulse length and energy for fixed laser power. For example, 
instead of using ultra-short Ti:sapphire lasers perhaps sub-picoseconds ceramic lasers 
may serve a purpose because of such scaling. This point may become even more 
important in the further innovation of adiabatic acceleration discussed in next 
subsection D. 
Adiabatic acceleration 
 
Since the initial proton acceleration experiment11 in 2000 at Lawrence Livermore 
National Laboratory (LLNL), all laser experiments so far have been of the sudden type 
(and non-adiabatic). In these experiments the focused intense laser irradiates a solid 
target such as aluminum foil, in which the speed of the electrons reaches the speed of 
light instantaneously (MeV/μm). In this process the laser energy is first transferred to 
the electron kinetic energy and then to electrostatic potential energy (and 
electromagnetic energy due to the large electronic current generated), which in part is 
converted into the ion kinetic energy.  The high density of the target electrons makes 
the charge separation propagation temporarily stationary followed by acceleration. 
However, collective acceleration often suffers from the detachment of the laser energy 
in electrons from that of ions.64 To overcome this problem in laser ion acceleration, 
the concept of adiabatic (gradual) change of the accelerating medium was 
introduced.65 If and when we can adopt adiabatic65 (i.e. gradual) acceleration, instead 
of non-adiabatic (i.e. sudden) acceleration in most (or all) current experiments, we 
should expect the conversion efficiency from laser energy to charged particle energy 
to greatly increase. We envision that the adiabaticity of acceleration may be 
introduced by a variety of techniques not limited by the one originally proposed.65 For 
example, Bulanov et al. have already shown the gradual slope of the density can help 
introduce adiabatic acceleration.66 
Unlike the sudden sheath blowout scaling discussed above in C, the energy of ions 
depends on a different set of conditions. The optimal condition of the laser pulse 
coupling with the plasma slab is introduced, i. e. the condition 
                             σ=0a  .                                 (7)                                 
Together with Eq.(4), Eq.(7) yields Eq.(1) once again. This condition is written as 
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The laser pulse loses a substantial part of its energy after it has propagated over the 
depletion length3  
 
⎟⎠
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lasdep ??
 .                                                  (9) 
From Eqs. (8) and (9) we find the matching condition between the target length and 
the laser pulse amplitude:  
 
                                                λ
lasa ?=0
 .            (10)
                                                    
Here we optimize the thickness of the target to be ℓlas =ℓpl . 
From above written relationships we obtain a scaling for the adiabatically accelerated 
ion energy in the case of one layer target. It is  
2
2
⎟⎟⎠
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e
pl
ep d
cm
?ε
 ,                                           (11) 
where de=c /ωpe is the collisionless skin depth, ωpe = (4π nee2/mγ)1/2  is the plasma 
frequency and γ is the Lorentz factor of electrons (γ ~a0 when a0 >> 1 ). 
In order to provide the matching between the laser pulse and target in the transverse 
direction, we suggest using the preformed channel with the parabolic profile of the 
plasma density inside. In this case the matching condition is expressed as  
 
Rlas λ=?  ,                                                      (12) 
where R is the channel radius with R >lpl. The optimal situation for the electric field 
generation occurs when ℓlas =ℓpl.  Note that the plasma thickness is now substantially 
enhanced to realize adiabatic (gradual) acceleration. On the other hand, we shall see in 
what follows that the density of the plasma for optimal acceleration is substantially 
less than the usual solid density. The laser pulse shape also affects its energy depletion 
length value. A suitably shaped laser pulse loses less energy during interaction with 
the same profile target.  
 In order to achieve the energy higher than that given in (11) we consider the graded 
layer target, in which the relatively high plasma density slab is followed by the 
inhomogeneous corona with the gradually decreasing density. The ion energy gain can 
be estimated to be  
 
Rlas λ=?  ,                                                        (13) 
 
where the electric field is given by E(x)=en(x) ℓlas(x) with Rlas λ=?  and 
2/2iip vm=ε . Rewriting Eq. (13) as  
 
 
)()(
)(
)( 2 xRxne
dx
xdv
xvm iii λ=
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and imposing the condition of adiabatic acceleration,  
 
)()( xVxvi = ,                                                          (15) 
 
where V(x) is the propagation velocity for the accelerating structure, we obtain the 
equation for the target parameters, n(x) and R(x). The velocity V(x) is determined by 
the physical mechanism of the electric field generation. The electric field can be 
produced either by the fast electrons accelerated in the plasma, or by the laser pulse 
ponderomotive pressure, or by the pressure of quasistatic magnetic field generated by 
the fast electron electric current. 
As an illustration, we consider the case when the velocity V(x) is equal to the laser 
pulse group velocity vg(x), which is given by  
  
ω
ωω )(
)(
2 x
cxv peg
−=
2
.                                       (16) 
We note that vg(x) can be controlled by changing the electron density. We further note 
that we can make the group velocity equal to zero (or very small) when we need to 
pick up ions and that we can make it increase as ions gain energy. This is the essence 
of the innovation of adiabatic acceleration. 
Assuming the channel radius, R, to be constant, we find from Eqs. (14)-(16) the 
exponential profile of the plasma density in the corona to be: 
1/ 2
0( ) exp e
i
m x Rn x n
m
π λ λ
⎡ ⎤⎛ ⎞= −⎢ ⎥⎜ ⎟⎝ ⎠⎢ ⎥⎣ ⎦ .                                      (17) 
 
For typical parameters, / 2000i em m ≈ , / 20R λ ≈ , and 1 mλ μ≈ , we find that the 
inhomogeneity scale for the plasma corona is of order several hundred microns. 
Innovations that are based on insight from the optimizations discussed in this 
section, affords opportunity to physically realize compact and relatively 
uncomplicated/uncluttered accelerator systems for beam therapy. 
 
CLINICAL APPLICATIONS 
 
The combination narrow spot irradiation of laser-driven proton beams coupled with 
shallow target depth is ideal for an accurate radiotherapy treatment of shallow diseases. 
A narrow pencil beam of protons will suffer less angular spread due to multiple 
scattering over the short (several cm) distance to the shallow site of the disease. Such 
angular broadening increases with increased target depth and limits spatial resolution 
of the treatment volume.  
We are in the early stages of feasibly developing facilities for hadron therapy of 
oncological diseases. Some key questions arise. Among them are: Can we use a laser 
driven proton accelerator for clinical practice? What kind of disease will be treated? 
When can the laser driven accelerator be achieved? Why is the accelerator necessary? 
Table 2 answers some of these questions. At present, because the laser accelerated 
proton energy is relatively low, clinical application is limited to diseases existing only 
a few centimeters under the skin such as small tumors in the eye, thyroid, larynx, nasal 
or paranasal cavity, breast, superficial lymph node (LN), skin and subcutaneous tissue. 
One possibility based on HIBMC experiences is to utilize the laser driven accelerator 
in combination with the standard particle accelerator. This is because the current 
particle accelerators can generate ion energies high enough to be suitable for deep 
seated tumors and the laser driven accelerator presently generates lower energy ions. 
 
 
TABLE2.Comparison between a conventional particle accelerator (synchrotron/cyclotron) and a laser 
proton accelerator (as of the present). As discussed in the text, in the future with a higher-power and 
better-controlled laser and a better design of the target, it may be possible for laser accelerators to reach 
energies comparable with conventional accelerators. Rapid development in both of these areas is 
expected. 
 
 
Below we discuss earlier and easier goals for proton radiotherapy that are derived 
from the advantageous features as well as today’s limitations that characterize laser 
driven ion acceleration.  
In the case of proton therapy of age-related macular degeneration (ARMD), the 
development of a dedicated machine only for ARMD is indispensable as evidenced by 
the accurate targeting shown in Figs. 8c and 8d. Because patients develop ARMD in 
0.67% (320,000 people) of the population at the age of 50 or over (49,000,000 people) 
in Japan, and 1.7 % (830,000 people) a year in a more recent report,67 many patients 
cannot be treated  in current conventional accelerator facilities. 
Simulation studies have shown that laser accelerated protons and particle selection 
systems have the capability to deliver superior radiation therapy treatment.31 With our 
PIC and Monte-Carlo simulation, we demonstrated treatment planning for eye diseases 
which may be treated using the spot-scanning technique by laser ion accelerated 
Accelerator Systems  
Synchrotron or Cyclotron Laser ions at present 
Size of machine large  (Ф30m in HIBMC) 
small  
(table top) 
Cost Expensive  (23 billion yen at HIBMC) Relatively inexpensive 
Energy up to 230MeV in HIBMC several tens of MeV(at present) 
Change of 
energy much time easy and rapid 
Range 32cm (whole body) 
several cm 
(superficial tumor) 
Beam size about 10mm <1mm (at source) 
Operation time Now available 
Petawatt laser JAEA 
2001(experimental) 
Fox Chase laser 2006 ( small size, 
experimental) 
GIST laser 2006 (small size, 
experimental) 
Clinical 
applications solid tumor in the body 
small sized tumors in the eye, 
thyroid, larynx, nasal or paranasal 
cavity, breast, superficial LN, skin, 
subcutaneous 
intraoperative or intracavital proton 
RT 
proton beams.46 Using PIC simulations the possible available proton beam energies 
with currently available lasers were determined.  Based on these results various input 
parameters were chosen for the Monte-Carlo simulations with GEANT4.  We show 
the results for the cases: Uveal melanoma and ARMD.  In both cases the energies are 
somewhat higher due to the propagation of the beam through bone tissue.  
Uveal melanoma (Figs. 8a and 8b)68 69  
The proton radiotherapy for uveal melanomas was simulated. Minute proton beams 
delivered a range of the kinetic energy to the target spots. A right oblique portal was 
adopted to minimize exposure to the normal structures of the eye.  The energy range 
was from 38 to 81 MeV using a Gaussian beam energy spread of 10%. Proton therapy 
may be used for patients who are not suitable for more conservative therapies. 69 
ARMD (Figs. 8c and 8d) 
Left lateral proton irradiation was planned. The clinical target volume was settled on 
the macula of the left eye. The iso-dose curve shows the advantage of proton 
radiotherapy. The parameters are the same as in the previous case, but the energy 
range was from 61 to 75 MeV.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8.Monte Carlo simulation of the spot-scanning simulation of laser proton radiotherapy for eye 
melanoma (a,b) and ARMD (c,d). Particle-in-cell simulation (PIC) results are used to determine the 
properties of laser-accelerated protons. Based on these results parameters are then chosen for the input 
into the Monte-Carlo simulation code and visualization tools for the dose evaluation are used to image 
the results. The initial input parameters are determined by forward planning. After the Monte-Carlo 
simulation, the particle counts were fine tuned to achieve a smooth dose distribution. Curves correspond 
to 25%, 50%, 75%, 90% and 110% of the required dose. 
 
CONCLUSIONS 
 
The laser proton accelerator concept has characteristics that are compact and 
enables new ways to practice radio-therapy. A laser driven proton accelerator can 
facilitate changing the proton energy easily and rapidly such that fine scanning 
irradiation using a minute spot becomes easily realized as demonstrated in our Monte-
Carlo dose distribution simulation. We have shown that the compactness of the system 
makes more readily available in situ real-time diagnostics such as PET for realizing 
BCRT. The optimization techniques for proton energy maximization and a new 
acceleration method (adiabatic acceleration) introduced in the present work contribute 
to greatly increase the achievable ion energy for a given laser intensity and to enhance 
the conversion efficiency of laser energy to charged particle energy. Presently 
available laser accelerated proton sources may be used for treating shallow tumors and 
ARMD as an earlier adoption of the laser acceleration technique to medical 
applications. We should not underestimate technical challenges lying ahead for 
clinical usage starting from the currently available parameters, while we proceed to 
resolve each of these issues with the consorted efforts of the medical, physical, and 
computational communities. Radically different from the conventional accelerator, the 
laser ion accelerator is small and suitable for a minute target and has great potential to 
improve the availability and the method of ion therapy with a series of innovations in 
the future. It is important to further intensify research in the field for the advancement 
of the current technique. 
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